GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo

Neuron

Volumn 15, Issue 6, 1995, Pages 1465-1473

  Arenas, Ernest ^a   Trupp, Miles ^a   Åkerud, Peter ^a   Ibáñez, Carlos F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMFONELIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE EXPRESSION; GENETIC ENGINEERING; GLIA CELL; HUNTINGTON CHOREA; INTRAPERITONEAL DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; NERVE SPROUTING; NONHUMAN; NORADRENERGIC NERVE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RAT;

ANIMALS; CELL LINE; GENETIC ENGINEERING; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; LOCUS COERULEUS; MALE; NERVE DEGENERATION; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; NOREPINEPHRINE; OXIDOPAMINE; PHENOTYPE; RATS; RATS, INBRED F344; RNA, MESSENGER;

EID: 0029584686     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0896-6273(95)90024-1     Document Type: Article

References (51)

1. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo
2. Involvement of the locus coeruleus in Pick's disease with or without Pick body formation
3. Neurobiology of the locus coeruleus
4. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
5. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
6. Hydrogen peroxide mediates amyloid β protein toxicity
7. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia
8. Parkinson's disease and dementia: norepinephrine and dopamine in locus coeruleus
9. Alterations in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease
10. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of Alzheimer's type, and in Parkinson's disease with and without dementia
11. Pathological correlates of dementia in Parkinson's disease
12. Selective loss of central cholinergic neurons in Alzheimer's disease
13. Lack of neurotrophin-3 leads to deficiences in the peripheral nervous system and loss of limb proprioceptive afferents
14. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3
15. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence
16. The pathology of Parkinson's disease
17. Differential actions of neurotrophins in the locus-coeruleus and basal forebrain
18. Dementia in idiopathic Parkinson's disease
19. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease
20. Diseasespecific patterns of locus coeruleus cell loss
21. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
22. Transmitter deficits in Alzheimer's disease
23. Noradrenergic and locus coeruleus modulation of the perforant path-evoked potential in rat dentate gyrus supports a role for the locus coeruleus in attentional and memorial processes
24. Zur Pathologie der Paralysis agitans and des postenzephalitischen Parkinsonismus
25. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle
26. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
27. Biochemical pathophysiology of Parkinson's disease
28. Pathology of Parkinson's disease: changes other than the nigrostriatal pathway
29. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo
30. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neruons
31. Pathological basis for neurotransmitter changes in Parkinson's disease
32. The pathology of human locus coeruleus
33. The topography of cell loss from locus coeruleus in Alzheimer's disease
34. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice
35. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine metabolism and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of the disease
36. Developing motor neurons rescued from programmed cell death by GDNF
37. The number of nerve cells in the substantia nigra in paralysis agitans
38. TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons
39. Regional and cell-specific expression of GDNF in rat brain
40. Parkinson's disease: sensory and motor problems in arms and hands
41. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo
42. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
43. Cell loss in the locus coeruleus in senile dementia of the Alzheimer type
44. Neuropathology of the locus coeruleus: a semiquantitative study
45. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons
46. OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts
47. Alzheimer's diseaseand seniledementia: loss of neurons in the basal forebrain
48. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons
49. The neuropathology of aminergic nuclei in Alzheimer's disease
50. The locus coeruleus and dementia in Parkinson's disease